Infusion reactions, also known as acute infusion reactions or infusion-related reactions, are common adverse effects that can occur when a person receives medication intravenously. Infusion reactions ...
Pre-medication regimen showed an infusion-related reaction rate of 22.5 percent with intravenous RYBREVANT ®, a three-fold reduction from 67.4 percent historically seen with standard IRR management ...
Daratumumab is an anti-CD38 monoclonal antibody used to treat multiple myeloma and light chain amyloidosis. Because daratumumab may cause reactions after intravenous or subcutaneous (SC) ...
Kisunla (donanemab-azbt) is a prescription drug used to treat Alzheimer’s disease. Kisunla can cause side effects that range from mild to serious. Examples include headache and infusion-related ...
Monoclonal antibodies (elotuzumab and daratumumab) are the newest class of drugs that have proven to be efficacious antimyeloma agents. Although daratumumab, a CD38 monoclonal antibody, has ...
For people living with primary immunodeficiency (PI), immunoglobulin replacement therapy is an essential part of preventing serious infections. The treatment can be delivered through an IV ...
Fabrazyme (agalsidase beta) is a brand-name intravenous (IV) infusion that’s prescribed for Fabry disease in adults and certain children. As with other drugs, Fabrazyme can cause side effects, such as ...
Briumvi (ublituximab-xiiy) is a prescription drug used to treat certain types of multiple sclerosis (MS). Briumvi can cause side effects that range from mild to serious. Examples include upper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results